In the month of October, the portfolio gained 5.2%, outperforming the benchmark S&P/ASX Small Ordinaries Accumulation Index by 4.7%.
Global markets declined in October, but Australia shares were broadly higher, the S&P/ASX 200 Accumulation was up 1.9% and S&P/ASX Small Ordinaries Accumulation was up 0.5%. The acceleration of Covid-19 in Europe and the US was the main concern, with lockdowns in key European cities and the US unable to pass additional stimulus measures. We remain positive about the trajectory of the portfolio. Lower interest rates continues to fuel investment into shares and the Australian government stimulus measures should amplify returns in small cap equities.
We aim to achieve superior returns to the ASX Small Ordinaries Accumulation Index by investing in high growth companies. Our investment process incorporates environmental and social factors in addition to achieving our returns.